Turnover Rate

The turnover rate in insurance refers to the rate at which employees leave a company and are replaced by new employees over a certain period. This is an important metric for insurers to track as high turnover rates can indicate issues with company culture, compensation, or other factors that can impact business operations.  

Here are some key features of turnover rate in insurance:

  • Definition: Turnover rate is calculated as the number of employees who leave a company (either voluntarily or involuntarily) divided by the total number of employees in the company, expressed as a percentage.
  • Importance: High turnover rates can indicate problems with company culture, management, compensation, or other issues that can negatively impact employee morale and the overall success of the business.
  • Calculation: To calculate turnover rate, divide the number of employees who left the company during a given period by the average number of employees during that period. Then multiply by 100 to get the percentage.  
  • Benchmark: Turnover rates can vary depending on the industry and company size, but a generally accepted benchmark is around 10-15% annually.  

Example: If a company has 100 employees at the beginning of the year and 20 employees leave during the year, the turnover rate for the year is 20% ((20/100) x 100).  

Overall, turnover rate is an important metric for insurers to track as it can provide insights into the health of the company culture and workforce. By monitoring and addressing high turnover rates, insurers can work to improve retention and ultimately enhance the success of their business.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.